Non-convulsive status epilepticus in brain tumors.

M. Casazza, I. Gilioli

Research output: Contribution to journalArticle

Abstract

Epileptic seizures are very common in brain tumors, depending on histology and tumor site. In low-grade gliomas, it can be the only symptom reaching the 100% of incidence. Pathophysiology is multifactorial and still not perfectly understood. In a high percentage of cases, epilepsy is pharmacoresistant. Surgical resection of tumors can cure it. It happens more easily in low-grade gliomas, with a preoperative epilepsy evaluation, followed by a tailored surgery, not limited to lesionectomy, and including the peritumoral epileptic focus. In high-grade gliomas, postoperative epilepsy recurrence cannot only be due to tumor recurrence, but also to bad pharmacological compliance, or to pharmacoresistance. Seizures may be clustered in a non-convulsive status epilepticus. This condition must be recognized, because it may mimic a neurological worsening due to other reasons, as it presents with confusion, aphasia, and disorientation. EEG monitoring can help recognize the status. The treatment does not differ from that of non-convulsive status, due to other etiologies, but non-inducing AEDs are preferred.

Original languageEnglish
JournalNeurological Sciences
Volume32 Suppl 2
Publication statusPublished - Nov 2011

Fingerprint

Status Epilepticus
Brain Neoplasms
Epilepsy
Glioma
Recurrence
Neoplasms
Aphasia
Compliance
Electroencephalography
Histology
Seizures
Pharmacology
Incidence
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Non-convulsive status epilepticus in brain tumors. / Casazza, M.; Gilioli, I.

In: Neurological Sciences, Vol. 32 Suppl 2, 11.2011.

Research output: Contribution to journalArticle

@article{c8fb344b3c004e92abdd1daa1a0ee554,
title = "Non-convulsive status epilepticus in brain tumors.",
abstract = "Epileptic seizures are very common in brain tumors, depending on histology and tumor site. In low-grade gliomas, it can be the only symptom reaching the 100{\%} of incidence. Pathophysiology is multifactorial and still not perfectly understood. In a high percentage of cases, epilepsy is pharmacoresistant. Surgical resection of tumors can cure it. It happens more easily in low-grade gliomas, with a preoperative epilepsy evaluation, followed by a tailored surgery, not limited to lesionectomy, and including the peritumoral epileptic focus. In high-grade gliomas, postoperative epilepsy recurrence cannot only be due to tumor recurrence, but also to bad pharmacological compliance, or to pharmacoresistance. Seizures may be clustered in a non-convulsive status epilepticus. This condition must be recognized, because it may mimic a neurological worsening due to other reasons, as it presents with confusion, aphasia, and disorientation. EEG monitoring can help recognize the status. The treatment does not differ from that of non-convulsive status, due to other etiologies, but non-inducing AEDs are preferred.",
author = "M. Casazza and I. Gilioli",
year = "2011",
month = "11",
language = "English",
volume = "32 Suppl 2",
journal = "Neurological Sciences",
issn = "1590-1874",
publisher = "Springer-Verlag Italia s.r.l.",

}

TY - JOUR

T1 - Non-convulsive status epilepticus in brain tumors.

AU - Casazza, M.

AU - Gilioli, I.

PY - 2011/11

Y1 - 2011/11

N2 - Epileptic seizures are very common in brain tumors, depending on histology and tumor site. In low-grade gliomas, it can be the only symptom reaching the 100% of incidence. Pathophysiology is multifactorial and still not perfectly understood. In a high percentage of cases, epilepsy is pharmacoresistant. Surgical resection of tumors can cure it. It happens more easily in low-grade gliomas, with a preoperative epilepsy evaluation, followed by a tailored surgery, not limited to lesionectomy, and including the peritumoral epileptic focus. In high-grade gliomas, postoperative epilepsy recurrence cannot only be due to tumor recurrence, but also to bad pharmacological compliance, or to pharmacoresistance. Seizures may be clustered in a non-convulsive status epilepticus. This condition must be recognized, because it may mimic a neurological worsening due to other reasons, as it presents with confusion, aphasia, and disorientation. EEG monitoring can help recognize the status. The treatment does not differ from that of non-convulsive status, due to other etiologies, but non-inducing AEDs are preferred.

AB - Epileptic seizures are very common in brain tumors, depending on histology and tumor site. In low-grade gliomas, it can be the only symptom reaching the 100% of incidence. Pathophysiology is multifactorial and still not perfectly understood. In a high percentage of cases, epilepsy is pharmacoresistant. Surgical resection of tumors can cure it. It happens more easily in low-grade gliomas, with a preoperative epilepsy evaluation, followed by a tailored surgery, not limited to lesionectomy, and including the peritumoral epileptic focus. In high-grade gliomas, postoperative epilepsy recurrence cannot only be due to tumor recurrence, but also to bad pharmacological compliance, or to pharmacoresistance. Seizures may be clustered in a non-convulsive status epilepticus. This condition must be recognized, because it may mimic a neurological worsening due to other reasons, as it presents with confusion, aphasia, and disorientation. EEG monitoring can help recognize the status. The treatment does not differ from that of non-convulsive status, due to other etiologies, but non-inducing AEDs are preferred.

UR - http://www.scopus.com/inward/record.url?scp=84859468248&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859468248&partnerID=8YFLogxK

M3 - Article

C2 - 21987289

VL - 32 Suppl 2

JO - Neurological Sciences

JF - Neurological Sciences

SN - 1590-1874

ER -